DK1206248T3 - Sedativ-hypnotiske præparater med kontrolleret frigivelse og fremgangsmåder relaterede dertil - Google Patents

Sedativ-hypnotiske præparater med kontrolleret frigivelse og fremgangsmåder relaterede dertil

Info

Publication number
DK1206248T3
DK1206248T3 DK00961399T DK00961399T DK1206248T3 DK 1206248 T3 DK1206248 T3 DK 1206248T3 DK 00961399 T DK00961399 T DK 00961399T DK 00961399 T DK00961399 T DK 00961399T DK 1206248 T3 DK1206248 T3 DK 1206248T3
Authority
DK
Denmark
Prior art keywords
sedative
hypnotic
compound
controlled
preparations
Prior art date
Application number
DK00961399T
Other languages
Danish (da)
English (en)
Inventor
D Bruce Campbell
W Jay Thiele
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of DK1206248T3 publication Critical patent/DK1206248T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00961399T 1999-08-26 2000-08-28 Sedativ-hypnotiske præparater med kontrolleret frigivelse og fremgangsmåder relaterede dertil DK1206248T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38444899A 1999-08-26 1999-08-26
PCT/US2000/023665 WO2001013895A2 (fr) 1999-08-26 2000-08-28 Compositions hypnotiques sedatives a liberation controllee et procedes correspondants

Publications (1)

Publication Number Publication Date
DK1206248T3 true DK1206248T3 (da) 2003-09-29

Family

ID=23517364

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00961399T DK1206248T3 (da) 1999-08-26 2000-08-28 Sedativ-hypnotiske præparater med kontrolleret frigivelse og fremgangsmåder relaterede dertil

Country Status (9)

Country Link
EP (2) EP1206248B1 (fr)
JP (1) JP2003507413A (fr)
AT (1) ATE241968T1 (fr)
AU (1) AU7335500A (fr)
DE (1) DE60003194T2 (fr)
DK (1) DK1206248T3 (fr)
ES (1) ES2199857T3 (fr)
PT (1) PT1206248E (fr)
WO (1) WO2001013895A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
WO2005027877A1 (fr) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotique, son utilisation et sa formulation
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20070020333A1 (en) * 2005-07-20 2007-01-25 Chin-Chih Chiang Controlled release of hypnotic agents
EP1970056A1 (fr) * 2007-03-15 2008-09-17 Polichem S.A. Formules de dosages à libération retardée/pulsatile spécifique au temps
TW201200165A (en) * 2010-02-22 2012-01-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
ES2706880T3 (es) 2010-02-22 2019-04-01 Daiichi Sankyo Co Ltd Preparación sólida de liberación sostenida para uso oral
CN102670613A (zh) * 2011-03-16 2012-09-19 中国人民解放军军事医学科学院毒物药物研究所 用于改善茚地普隆溶出的药物组合物及其制备方法
RU2665372C2 (ru) 2012-09-03 2018-08-29 Дайити Санкио Компани, Лимитед Пероральная фармацевтическая композиция замедленного высвобождения, содержащая гидрохлорид гидроморфона
CN110604727A (zh) * 2014-02-06 2019-12-24 序列药品有限公司 用于帮助睡眠的组合物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
EP1064937A1 (fr) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Formes pharmaceutiques à liberation controllée comprenant un hypnotique à courte duree ou une des ses sels
US6472528B1 (en) * 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines

Also Published As

Publication number Publication date
ES2199857T3 (es) 2004-03-01
DE60003194T2 (de) 2004-06-17
EP1352647A1 (fr) 2003-10-15
EP1206248B1 (fr) 2003-06-04
WO2001013895A2 (fr) 2001-03-01
JP2003507413A (ja) 2003-02-25
ATE241968T1 (de) 2003-06-15
AU7335500A (en) 2001-03-19
PT1206248E (pt) 2003-11-28
WO2001013895A3 (fr) 2001-09-27
DE60003194D1 (de) 2003-07-10
EP1206248A2 (fr) 2002-05-22

Similar Documents

Publication Publication Date Title
GB9811427D0 (en) Chemical compounds
TNSN03108A1 (en) Once-a-day oxycodone formulations
BG106586A (en) Pyrazolopyramidines as therapeutic agents
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
EP1222922A4 (fr) Procede de stabilisation de composes benzimidazoles
DZ2503A1 (fr) Formulation pure injectable d'un composé anesthésique.
EP1274443A4 (fr) Micelles
ATE241968T1 (de) Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren
MX9605458A (es) Derivados de amida y su uso terapeutico.
BRPI9916820A2 (pt) Formulações farmacêuticas
NO985202L (no) Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater
BG106520A (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
GB9930358D0 (en) Process for the preparation of chemical compounds
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
MXPA02011410A (es) Uso de compuestos 1-amino-5-fenilpentan-3-ol y/o 1-amino-6-fenilhexan-3-ol substituidos como medicamentos.
ATE282608T1 (de) Chinoxalindionen
GB2402335B (en) Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1,5-bipyridazine in nanoparticulate form
ATE96144T1 (de) 2-aminoacetamid derivate.
ECSP951538A (es) Derivados de quinoxalina utiles en terapia
IL110369A0 (en) Pharmaceutical compositions for the prevention and/or treatment of gastrointestinal diseases including ulcer
ECSP003706A (es) Compuestos farmaceuticamente activos